Loading data
OMERNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 81.3 m USD | 119.52 m USD | 114.87 m USD | 112.72 m USD | 118.78 m USD |
| Selling, general and administrative expense | 41.5 m USD | 47.43 m USD | 49.66 m USD | 50.67 m USD | 54.84 m USD |
| Operating profit | -122.8 m USD | -166.95 m USD | -164.53 m USD | -163.39 m USD | -173.62 m USD |
| Interest expense | — | — | 30.84 m USD | 22.7 m USD | 19.67 m USD |
| Profit before tax | -2.8 m USD | -180.32 m USD | -174.92 m USD | -182.03 m USD | -191.55 m USD |
| Income tax expense | 2.01 m USD | 2.31 m USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -3.35 m USD | -156.82 m USD | -117.81 m USD | 47.42 m USD | 194.24 m USD |
| Basic earnings per share | -0.05 USD/share | -2.7 USD/share | -1.88 USD/share | 0.76 USD/share | 3.12 USD/share |
| Diluted earnings per share | -0.05 USD/share | -2.7 USD/share | -1.88 USD/share | 0.76 USD/share | 3.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.